Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OXN vs OXY for OIC in Chronic Low Back Pain
NCT01427283Phase 3Completed
- Sponsor
- Purdue Pharma
- Start
- Aug 2011
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of oxycodone + naloxone in opioid-induced constipation (OIC), chronic low back pain (CLBP), sponsored by Purdue Pharma. Started Aug 2011; status: completed.
02
Drugs
oxycodone + naloxone
03
Conditions
opioid-induced constipation (OIC)chronic low back pain (CLBP)
Beyond the preview
Go deeper on NCT01427283.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01427283.